Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity

被引:6
作者
Cao, Gang [1 ,2 ]
Hu, Shaoqi [2 ]
Ning, Yan [2 ]
Dou, Xinyue [2 ]
Ding, Chuan [2 ]
Wang, Lu [2 ]
Wang, Zeping [2 ]
Sang, Xianan [2 ]
Yang, Qiao [2 ]
Shi, Jiangnan [2 ]
Hao, Min [2 ]
Han, Xin [2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Innovat Inst Chinese Med & Pharm, Chengdu, Peoples R China
[2] Zhejiang Chinese Med Univ, Sch Pharm, Hangzhou, Peoples R China
关键词
osteoporosis; pathogenesis; pathogenic factors; traditional Chinese medicine; treatment; BONE-MINERAL DENSITY; MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; HERBAL MEDICINE; TGF-BETA; SALVIA-MILTIORRHIZA; PROMOTES; DISEASE; RUNX2;
D O I
10.3389/fphar.2024.1370900
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Osteoporosis characterized by decreased bone density and mass, is a systemic bone disease with the destruction of microstructure and increase in fragility. Osteoporosis is attributed to multiple causes, including aging, inflammation, diabetes mellitus, and other factors induced by the adverse effects of medications. Without treatment, osteoporosis will further progress and bring great trouble to human life. Due to the various causes, the treatment of osteoporosis is mainly aimed at improving bone metabolism, inhibiting bone resorption, and promoting bone formation. Although the currently approved drugs can reduce the risk of fragility fractures in individuals, a single drug has limitations in terms of safety and effectiveness. By contrast, traditional Chinese medicine (TCM), a characteristic discipline in China, including syndrome differentiation, Chinese medicine prescription, and active ingredients, shows unique advantages in the treatment of osteoporosis and has received attention all over the world. Therefore, this review summarized the pathogenic factors, pathogenesis, therapy limitations, and advantages of TCM, aiming at providing new ideas for the prevention and treatment of OP.
引用
收藏
页数:18
相关论文
共 170 条
[1]   Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases [J].
Amarasekara, Dulshara Sachini ;
Yu, Jiyeon ;
Rho, Jaerang .
JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
[2]   Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation [J].
An, Jing ;
Yang, Hao ;
Zhang, Qian ;
Liu, Cuicui ;
Zhao, Jingjing ;
Zhang, Lingling ;
Chen, Bo .
LIFE SCIENCES, 2016, 147 :46-58
[3]  
Andreoli A, 2011, RADIOL MED, V116, P1115, DOI 10.1007/s11547-011-0689-2
[4]   Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis A Living Systematic Review and Network Meta-analysis for the American College of Physicians [J].
Ayers, Chelsea ;
Kansagara, Devan ;
Lazur, Brittany ;
Fu, Rongwei ;
Kwon, Amy ;
Harrod, Curtis .
ANNALS OF INTERNAL MEDICINE, 2023, 176 (02) :182-195
[5]  
BARRETTCONNOR E, 1992, JAMA-J AM MED ASSOC, V268, P3333
[6]   Flavonoids in Bone Erosive Diseases: Perspectives in Osteoporosis Treatment [J].
Bellavia, Daniele ;
Dimarco, Eufrosina ;
Costa, Viviana ;
Carina, Valeria ;
De Luca, Angela ;
Raimondi, Lavinia ;
Fini, Milena ;
Gentile, Carla ;
Caradonna, Fabio ;
Giavaresi, Gianluca .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (02) :76-94
[7]   WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression [J].
Cai, Ting ;
Sun, Danqin ;
Duan, Ying ;
Wen, Ping ;
Dai, Chunsun ;
Yang, Junwei ;
He, Weichun .
EXPERIMENTAL CELL RESEARCH, 2016, 345 (02) :206-217
[8]   Experimental and molecular docking studies of estrogen-like and anti-osteoporosis activity of compounds in Fructus Psoraleae [J].
Cai, Xin-Yin ;
Zhang, Zi-Jia ;
Xiong, Jing-Lin ;
Yang, Meng ;
Wang, Zheng-Tao .
JOURNAL OF ETHNOPHARMACOLOGY, 2021, 276
[9]   MANAGEMENT OF ENDOCRINE DISEASE Novel anabolic treatments for osteoporosis [J].
Canalis, Ernesto .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (02) :R33-R44
[10]   Effect and mechanism of psoralidin on promoting osteogenesis and inhibiting adipogenesis [J].
Cao, Hui-juan ;
Li, Cai-rong ;
Wang, Lin-ying ;
Ziadlou, Reihane ;
Grad, Sibylle ;
Zhang, Yan ;
Cheng, Yan ;
Lai, Yu-xiao ;
Yao, Xin-sheng ;
Alini, Mauro ;
Qin, Ling ;
Wang, Xin-luan .
PHYTOMEDICINE, 2019, 61